Helicos, Rosetta Shares Rose Sharply in January

While Helicos and Rosetta Genomics rose, shares of Cepheid were hit by its forecast of lower revenues. But, overall, the GWDN Index managed to gain ground while the broader market fell.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.